The recreational drug ecstasy disrupts the hypothalamic-pituitary-gonadal reproductive axis in adult male rats

Neuroendocrinology

Volumn 88, Issue 2, 2008, Pages 95-102

  Dickerson, Sarah M ^a   Walker, Deena M ^a   Reveron, Maria E ^a   Duvauchelle, Christine L ^a   Gore, Andrea C ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Ecstasy (MDMA); Endocrine disruption; Gonadotropin releasing hormone; Male reproduction; Testosterone

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; GONADORELIN; LUTEINIZING HORMONE; MESSENGER RNA; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; REPRODUCTION;

ANIMALS; ENDOCRINE DISRUPTORS; GENE EXPRESSION; GONADOTROPIN-RELEASING HORMONE; HYPOTHALAMIC DISEASES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; LUTEINIZING HORMONE; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCTION; STREET DRUGS; TESTIS; TESTOSTERONE;

EID: 50649124881     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000119691     Document Type: Article

References (59)

1. Strote J, Lee JE, Wechsler H: Increasing MDMA use among college students: results of a national survey. J Adolesc Health 2002;30:64-72.
2. Boyd C, McCabe S, d'Arcy H: Ecstasy use among college undergraduates: gender, race and sexual identity. J Subst Abuse Treat 2003;24:209-215.
3. Kalechstein AD, De La Garza R 2nd, Mahoney JJ 3rd, Fantegrossi WE, Newton TF: MDMA use and neurocognition: a meta-analytic review. Psychopharmacology (Berl) 2007;189:531-537.
4. Parrott AC, Lees A, Garnham NJ, Jones M, Wesnes K: Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits. J Psychopharmacol 1998;12:79-83.
5. Verkes RJ, Gijsman HJ, Pieters MS, Schoemaker RC, de Visser S, Kuijpers M, Pennings EJ, de Bruin D, Van de Wijngaart G, Van Gerven JM, Cohen AF: Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology (Berl) 2001;153:196-202.
6. Balogh B, Molnar E, Jakus R, Quate L, Olverman HJ, Kelly PA, Kantor S, Bagdy G: Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA. Psychopharmacology (Berl) 2004;173:296-309.
7. Dafters RI, Biello SM: The effect of 3,4-methylenedioxymethamphetamine ('ecstasy') on serotonergic regulation of the mammalian circadian clock mechanism in rats: the role of dopamine and hyperthermia. Neurosci Lett 2003;350:117-121.
8. Reveron ME, Maier EY, Duvauchelle CL: Experience-dependent changes in temperature and behavioral activity induced by MDMA. Physiol Behav 2006;89:358-363.
9. Banks ML, Sprague JE, Kisor DF, Czoty PW, Nichols DE, Nader MA: Ambient temperature effects on 3,4-methylenedioxymethamphetamine-induced thermodysregulation and pharmacokinetics in male monkeys. Drug Metab Dispos 2007;35:1840-1845.
10. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI: The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacol Rev 2003;55:463-508.
11. Stone DM, Merchant KM, Hanson GR, Gibb JW: Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Neuropharmacology 1987;26:1677-1683.
12. Schmidt CJ, Taylor VL: Depression of rat brain tryptophan hydroxylase following the acute administration of methylenedioxymethamphetamine. Biochem Pharmacol 1987;36:4095-4102.
13. Yamamoto BK, Spanos LJ: The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur J Pharmacol 1988;148:195-203.
14. Colado MI, O'Shea E, Granados R, Esteban B, Martín AB, Green AR: Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration. Br J Pharmacol 1999;126:911-924.
15. Bogen IL, Haug KH, Myhre O, Fonnum F: Short- and long-term effects of MDMA ('ecstasy') on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo. Neurochem Int 2003;43:393-400.
16. 1 receptors. Neuropsychopharmacology E-pub ahead of print. DOI 10.1038/sj.npp.1301512.
17. 3H]monoamines into synaptosomes from different regions of rat brain. Biochem Pharmacol 1987;36:2297-2303.
18. 3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues. Eur J Pharmacol 1991;200:9-16.
19. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS: Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 2001;39:32-41.
20. Fitzgerald JL, Reid JJ: Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices. Naunyn Schmiedebergs Arch Pharmacol 1993;347:313-323.
21. Fischer HS, Zernig G, Schatz DS, Humpel C, Saria A: MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum. Eur J Neurosci 2000;12:1385-1390.
22. Acquas E, Marrocu P, Pisanu A, Cadoni C, Zernig G, Saria A, DiChiara G: Intravenous administration of ecstasy (3,4-methylenedioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo. Eur J Pharmacol 2001;418:207-211.
23. Nair SG, Gudelsky GA: 3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat. Psychopharmacology (Berl) 2006;184:182-189.
24. Bankson MG, Yamamoto BK: Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release. J Neurochem 2004;91:852-859.
25. Drouva SV, Gallo RV: Further evidence for inhibition of episodic luteinizing hormone release in ovariectomized rats by stimulation of dopamine receptors. Endocrinology 1977;100:792-798.
26. Vitale ML, de las Nieves Parisi M, Chiocchio SR, Tramezzani JH: Serotonin stimulates gonadotrophin release by acting directly on the median eminence. Acta Physiol Pharmacol Latinoam 1985;35:473-479.
27. Gore AC, Terasawa E: Neural circuits regulating pulsatile luteinizing hormone release in the female guinea-pig: opioid, adrenergic and serotonergic interactions. J Neuroendocrinol 2001;13:239-248.
28. Gore AC: GnRH: The Master Molecule of Reproduction. Norwell, Kluwer Academic Publishers, 2002.
29. Schenk S, Gittings D, Johnstone M, Daniela E: Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology (Berl) 2003;169:21-27.
30. Vella S, Gussick J, Woller M, Waechter-Brulla D: Modification of cell perifusion for extended study of hormone release in the rat pituitary. Methods Cell Sci 2001;23:197-204.
31. Maffucci JA, Walker DM, Ikegami A, Woller MJ, Gore AC: The NMDA receptor subunit NR2b: effects on LH release and GnRH gene expression in young and middle-aged female rats, with modulation by estradiol. Neuroendocrinology 2007, E-pub ahead of print. DOI 10.1159/000111136.
32. Gore AC, Roberts JL, Gibson MJ: Mechanisms for the regulation of gonadotropin-releasing hormone gene expression in the developing mouse. Endocrinology 1999;140:2280-2287.
33. Schirman-Hildesheim TD, Bar T, Ben-Aroya N, Koch Y: Differential gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acid expression patterns in different tissues of the female rat across the estrous cycle. Endocrinology 2005;146:3401-3408.
34. Medhurst AD, Harrison DC, Read SJ, Campbell CA, Robbins MJ, Pangalos MN: The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J Neurosci Methods 2000;98:9-20.
35. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C(T)] Method. Methods 2001;25:402-408.
36. Peroutka SJ, Newman H, Harris H: Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1988;1:273-277.
37. Mas M, Farre M, De La Torre R, Roset PN, Ortuno J, Segura J, Cami J: Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 1999;290:136-145.
38. Solowij N, Hall W, Lee N: Recreational MDMA use in Sydney: a profile of 'ecstasy' users and their experiences with the drug. Br J Addict 1992;87:1161-1172.
39. El Majdoubi M, Ramaswamy S, Sahu A, Plant TM: Effects of orchidectomy on levels of the mRNAs encoding gonadotropin-releasing hormone and other hypothalamic peptides in the adult male rhesus monkey (Macaca mulatta). J Neuroendocrinol 2000;12:167-176.
40. Wagner CK: The many faces of progesterone: a role in adult and developing male brain. Front Neuroendocrinol 2006;27:340-359.
41. Kalra PS, Kalra SP: Circadian periodicities of serum androgens, progesterone, gonadotropins and luteinizing hormone-releasing hormone in male rats: the effects of hypothalamic deafferentation, castration and adrenalectomy, Endocrinology 1977;101:1821-1827.
42. Phelps SM, Lydon JP, O'Malley BW, Crews D: Regulation of male sexual behavior by progesterone receptor, sexual experience, and androgen. Horm Behav 1998;34:294-302.
43. Tillet Y, Caldani M, Batailler M: Anatomical relationships of monoaminergic and neuropeptide Y-containing fibres with luteinizing hormone-releasing hormone systems in the preoptic area of the sheep brain: immunohistochemical studies. J Chem Neuroanat 1989;2:319-326.
44. Chen WP, Witkin JW, Silverman AJ: Gonadotropin releasing hormone (GnRH) neurons are directly innervated by catecholamine terminals. Synapse 1989;3:288-290.
45. Arendash GW, Gallo RV: Serotonin involvement in the inhibition of episodic luteinizing hormone release during electrical stimulation of the midbrain dorsal raphe nucleus in ovariectomized rats. Endocrinology 1978;102:1199-1206.
46. Wada K, Hu L, Mores N, Navarro CE, Fuda H, Krsmanovic LZ, Catt KJ: Serotonin (5-HT) receptor subtypes mediate specific modes of 5-HT-induced signaling and regulation of neurosecretion in gonadotropin-releasing hormone neurons. Mol Endocrinol 2006;20:125-135.
47. Clemens JA, Tinsley FC, Fuller RW: Evidence for a dopaminergic component in the series of neural events that lead to the prooestrous surge of LH. Acta Endocrinol (Copenh) 1977;85:18-24.
48. Yoshida H, Paruthiyil S, Butler P, Weiner RI: Role of cAMP signaling in the mediation of dopamine-induced stimulation of GnRH secretion via D1 dopamine receptors in GT1-7 cells. Neuroendocrinology 2004;80:2-10.
49. De La Garza R 2nd, Fabrizio KR, Gupta A: Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns. Psychopharmacology (Berl) 2007;189:425-434.
50. Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC, Woods JH: Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ('ecstasy') and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology (Berl) 2003;166:202-211.
51. Trigo JM, Panayi F, Soria G, Maldonado R, Robledo P: A reliable model of intravenous MDMA self-administration in naïve mice. Psychopharmacology (Berl) 2006;184:212-220.
52. Beardsley PM, Balster RL, Harris LS: Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug Alcohol Depend 1986;18:149-157.
53. Lamb RJ, Griffiths RR: Self-injection of 3,4-methylenediox ymethamphet amine (MDMA) in the baboon. Psychopharmacology (Berl) 1987;91:268-272.
54. Lile JA, Ross JT, Nader MA: A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') with cocaine in rhesus monkeys. Drug Alcohol Depend 2005;78:135-140.
55. Ratzenboeck E, Saria A, Kriechbaum N, Zernig G: Reinforcing effects of MDMA ('ecstasy') in drug-naïve and cocaine-trained rats. Pharmacology 2001;62:138-144.
56. Gagnaire F, Micillino JC: Effects of triadimefon on extracellular dopamine, DOPAC, HVA and 5-HIAA in adult rat striatum. Toxicology 2006;217:91-104.
57. Caudle WM, Richardson JR, Wang M, Miller GW: Perinatal heptachlor exposure increases expression of presynaptic dopaminergic markers in mouse striatum. Neurotoxicology 2005;26:721-728.
58. Khan IA, Thomas P: Aroclor 1254 inhibits tryptophan hydroxylase activity in rat brain. Arch Toxicol 2004;78:316-320.
59. Khan IA, Thomas P: PCB congener-specific disruption of reproductive neuroendocrine function in Atlantic croaker. Mar Environ Res 2006;62(suppl):s25-s28.